Explore Cutting-Edge Clinical Trials and RWE Solutions
with OXON at COS 2025
April 3-4, 2025 | Barcelona
OXON will support as an exhibitor, showcasing expanded services and new developments in RWE.
Join OXON at booth E1 during the Annual Clinical Outsourcing Summit (COS 2025) on April 3rd and 4th in Barcelona. This event, themed “Driving Innovation and Excellence in Clinical Outsourcing for a Healthier Tomorrow,” gathers industry leaders to discuss pivotal advancements and future trends in clinical outsourcing. It serves as a critical meeting point for professionals from over 100 companies worldwide, ranging from pharmaceutical giants to innovative biotech firms.
The OXON team, specialized in leveraging Real-World Evidence (RWE) to drive innovations in clinical trial methodologies, comprises experts who have contributed to more than 100 publications in top medical journals like NEJM and Lancet. We are particularly proud of our work with the groundbreaking FDA/EMA-approved Win Ratio methodology, which significantly enhances the power and efficiency of trials, especially in the domains of rare diseases and early-phase trials.
During COS 2025, we will demonstrate how our unique RWE-driven approaches can support comprehensive drug development programs across all phases, from discovery through post-marketing. OXON’s commitment to excellence and innovation in clinical research has positioned us as a leader in the field, and we are eager to help biotech and pharma companies optimize their clinical research strategies.
Don’t miss our featured presentation on the first day titled “New FDA-accepted Pocock Win Ratio can increase power in trials and RWE studies.” This session will delve into how this innovative methodology can revolutionize trial outcomes by increasing statistical power and efficiency, offering substantial benefits across various study types.
To learn more about our cutting-edge services, schedule a personal meeting at the conference or arrange a virtual meeting at your convenience, please click the link below.
We look forward to meeting you in Barcelona and discussing how we can assist in enhancing your clinical research efforts and ultimately improving patient outcomes.